Design, synthesis and biological evaluation of triazolo[1,5-a]pyrimidinone derivatives as potent and orally efficacious WRN helicase inhibitors for MSI cancer therapy.
- DOI
- 10.1016/j.bmc.2026.118777
- Published
- 2026-08-13
- Container
- Bioorg Med Chem
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.bmc.2026.118777,
title = {Design, synthesis and biological evaluation of triazolo[1,5-a]pyrimidinone derivatives as potent and orally efficacious WRN helicase inhibitors for MSI cancer therapy.},
author = {Xiong Y and Jiang H and Zhang J and Lu J and Yang J and Lin G and Zhang C and Zhang W and Zeng Q and Shi J and Liu M and Jiang Y and Zhao Q and Wang C and He Y and Che C.},
year = {2026},
journal = {Bioorg Med Chem},
doi = {10.1016/j.bmc.2026.118777},
url = {https://doi.org/10.1016/j.bmc.2026.118777}
}RIS
TY - JOUR TI - Design, synthesis and biological evaluation of triazolo[1,5-a]pyrimidinone derivatives as potent and orally efficacious WRN helicase inhibitors for MSI cancer therapy. AU - Xiong Y AU - Jiang H AU - Zhang J AU - Lu J AU - Yang J AU - Lin G AU - Zhang C AU - Zhang W AU - Zeng Q AU - Shi J AU - Liu M AU - Jiang Y AU - Zhao Q AU - Wang C AU - He Y AU - Che C. PY - 2026 JO - Bioorg Med Chem DO - 10.1016/j.bmc.2026.118777 UR - https://doi.org/10.1016/j.bmc.2026.118777 ER -
APA
Y, X., H, J., J, Z., J, L., J, Y., G, L., C, Z., W, Z., Q, Z., J, S., M, L., Y, J., Q, Z., C, W., Y, H., & C., C. (2026). Design, synthesis and biological evaluation of triazolo[1,5-a]pyrimidinone derivatives as potent and orally efficacious WRN helicase inhibitors for MSI cancer therapy.. Bioorg Med Chem. https://doi.org/10.1016/j.bmc.2026.118777
Source records
- europe-pmc · retrieved 2026-09-26T05:46:57.395Z